Nalaganje...
Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report
A 67-year-old male patient who was diagnosed with primary myelofibrosis 4 years ago did not respond to conventional therapies. The splenomegaly progressively increased, which caused spleen infarctions and led to the decision to perform a splenectomy procedure. After splenectomy, the patient started...
Shranjeno v:
| izdano v: | Turk J Haematol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Galenos Publishing
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4451489/ https://ncbi.nlm.nih.gov/pubmed/26316489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjh.2013.0338 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|